Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Global Focus On South Africa Will Hasten Medtech Regulation

This article was originally published in Clinica

Executive Summary

Medical devices will be on the agenda, alongside pharma, at the next WHO regulatory forum – the 17th International Conference of Drug Regulatory Authorities (ICDRA). The meeting will be held in Cape Town, South Africa on November 29-December 2 2016. South Africa’s new Medicines Control Council (MCC) registrar Dr Joey Gouws will host the event.

You may also be interested in...

South Africa Finally Gets Medtech Regulations Over The Start Line

After several years of delays, restarts and revisions to plans, South Africa’s medical device regulatory system has taken a big step forward with the setting of a deadline for manufacturers, importers and distributors to license their establishments locally. SAHPRA, the new South African Health Products Regulatory Agency, is also slated to start soon, in spring 2017.

Top 100 Outlook 2021: Medtechs Look To Build On Experiences Of Serving Global Markets In A Pandemic

Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.

Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19

2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts